|
KIF18B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.391400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.848000E-01 |
| Normal-vs-Stage2 |
3.777800E-01 |
| Normal-vs-Stage3 |
9.259800E-01 |
| Normal-vs-Stage4 |
6.801000E-01 |
| Stage1-vs-Stage2 |
4.156400E-02 |
| Stage1-vs-Stage3 |
4.137000E-01 |
| Stage1-vs-Stage4 |
7.599200E-01 |
| Stage2-vs-Stage3 |
1.841240E-01 |
| Stage2-vs-Stage4 |
4.798100E-02 |
| Stage3-vs-Stage4 |
4.005000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.453600E-01 |
| Normal-vs-AfricanAmerican |
6.421400E-01 |
| Normal-vs-Asian |
6.496000E-01 |
| Caucasian-vs-AfricanAmerican |
2.990600E-01 |
| Caucasian-vs-Asian |
7.594600E-01 |
| AfricanAmerican-vs-Asian |
2.682200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.348000E-01 |
| Normal-vs-Female |
9.810400E-01 |
| Male-vs-Female |
6.298400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.227600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.484400E-01 |
| Normal-vs-Age(61-80Yrs) |
9.979200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.308810E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.998390E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.131600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.587400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.160620E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.183580E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.845580E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.402200E-01 |
| Classical-VS-Follicular |
1.69925999999876E-05 |
| Classical-VS-Other |
8.414400E-02 |
| Classical-VS-Normal |
6.287400E-01 |
| Tall-VS-Follicular |
8.977800E-03 |
| Tall-VS-Other |
3.113800E-01 |
| Tall-VS-Normal |
7.047200E-01 |
| Follicular-VS-Other |
6.888200E-01 |
| Follicular-VS-Normal |
2.330000E-01 |
| Other-VS-Normal |
4.931800E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.975400E-01 |
| Normal-vs-N1 |
9.389000E-01 |
| N0-vs-N1 |
6.822600E-01 |
|
|
